🔎 Trials Near Me

ホーム › 多発性硬化症 › テキサス

テキサスにおける多発性硬化症の臨床試験

テキサス内の拠点で、多発性硬化症に関する17件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト(英語)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Prime Clinical Research, Lewisville
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/10/01更新 · NCT06782490

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Austin
  • TG Therapeutics Investigational Trial Site, Austin
  • TG Therapeutics Investigational Trial Site, Austin
  • 他6件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/23更新 · NCT06433752

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345

Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis

  • The University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳以上 · 全性別 · 2026/09/17更新 · NCT07606742

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • ANESC Research- Site Number : 8400187, El Paso
  • North Texas Institute of Neurology & Headache - Plano- Site Number : 8400082, Plano
  • North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083, Plano
被験者募集中第3相
18歳〜60歳 · 全性別 · 2026/09/15更新 · NCT07325292

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

  • The University of Texas at Dallas, Richardson
被験者募集中
18歳〜65歳 · 全性別 · 2026/09/15更新 · NCT05958381

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Dell Medical School, University of Texas at Austin, Austin
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • Local Institution - 0133, El Paso
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/09/10更新 · NCT06408259

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

  • University of Texas at Austin, Austin
被験者募集中
18歳〜80歳 · 全性別 · 2026/08/17更新 · NCT07759115

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

  • UT Southwestern Medical Center (Ophthalmology CRU), Dallas
  • Neuro-Eye Clinical Trials, Houston
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/14更新 · NCT07623668

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Carum Research, Dallas
  • Saturn Research Solution, Plano
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/07/29更新 · NCT07225504

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

  • University of Texas Southwestern Medical Center, Dallas
  • ANESC Research, El Paso
  • Saturn Research Solutions, Plano
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/06/15更新 · NCT06735248

Care in Multiple Sclerosis (MS)

  • Baylor College of Medicine, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/05更新 · NCT07011914

Non-invasive BCI-controlled Assistive Devices

  • The University of Texas at Austin, Austin
被験者募集中健康なボランティア歓迎
18歳〜80歳 · 全性別 · 2026/05/01更新 · NCT05183152

Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS

  • Houston Methodist Hospital, Houston
被験者募集中
18歳以上 · 女性 · 2026/03/23更新 · NCT06072703

Multiple Sclerosis Implementation Network (Registry)

  • The University of Texas at Austin, Austin
  • The University of Texas Health Science Center at Houston (UTHealth Houston), Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/02/17更新 · NCT07415824

NARCOMS Registry: A Multiple Sclerosis Registry

  • UT Southwestern Medical Center, Dallas
被験者募集中観察研究
18歳以上 · 全性別 · 2025/11/13更新 · NCT01018537

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。